ELLEN B. RICHSTONE - 07 Jun 2024 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role
Director
Signature
/s/ John Brendan Doyle, Attorney-in-Fact
Issuer symbol
CGTX
Transactions as of
07 Jun 2024
Net transactions value
$0
Form type
4
Filing time
11 Jun 2024, 18:46:49 UTC
Previous filing
24 May 2024
Next filing
12 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGTX Common Stock Award $0 +8,500 +53% $0.000000 24,500 07 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGTX Stock Option (right to buy) Award $0 +8,500 $0.000000 8,500 07 Jun 2024 Common Stock 8,500 $1.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.
F2 The option vests in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney